Read + Share
Amedeo Smart
Independent Medical Education
Wang W, Chen LY, Walker RF, Chow LS, et al. SGLT2 Inhibitors Are Associated With Reduced Cardiovascular Disease in Patients With Type 2 Diabetes: An Analysis of Real-World Data. Mayo Clin Proc 2023;98:985-996.PMID: 37419588
Email
LinkedIn
Facebook
Twitter
Privacy Policy